What is the recommended dosing of mirtazapine for insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing of Mirtazapine for Insomnia

For insomnia treatment, mirtazapine should be administered at a dose of 7.5-15 mg once daily at bedtime. This lower dose range is most effective for insomnia due to mirtazapine's sedating properties, which are actually more pronounced at lower doses 1, 2.

Dosing Rationale and Mechanism

Mirtazapine's sedative effects are primarily mediated through:

  • Potent antagonism of histamine H1 receptors
  • Blockade of 5-HT2A and 5-HT2C serotonin receptors
  • These sedating effects are more prominent at lower doses (7.5-15 mg)

At higher doses (30-45 mg), mirtazapine's noradrenergic effects become more dominant, which can actually reduce the sedative properties 3, 4.

Dosing Algorithm for Insomnia

  1. Initial dose: Start with 7.5 mg (half of a 15 mg tablet) once daily at bedtime 5

    • This lower dose maximizes the sedative effect while minimizing side effects
  2. Titration: If inadequate response after 1-2 weeks, increase to 15 mg once daily at bedtime 2

    • Do not increase beyond 15 mg if the primary goal is treating insomnia
    • Higher doses (>15 mg) may reduce sedative effects due to increased noradrenergic activity
  3. Administration timing: Administer 30-60 minutes before desired sleep time 2, 3

Clinical Considerations

  • Onset of action: Sleep improvements may be observed within the first week of treatment 3, 4
  • Advantages over other sleep medications:
    • No significant tolerance development to sedative effects
    • No rebound insomnia upon discontinuation
    • Promotes sleep without disrupting sleep architecture

Side Effects to Monitor

  • Common side effects: Increased appetite, weight gain, dry mouth, dizziness 3, 6
  • Monitoring: Weight should be monitored regularly, especially in patients concerned about weight gain
  • Caution: May cause daytime sedation in some patients; assess for morning drowsiness

Important Caveats

  • While the FDA label for mirtazapine indicates a starting dose of 15 mg for depression 2, lower doses (7.5 mg) are commonly used off-label for insomnia 5
  • Mirtazapine is not FDA-approved specifically for insomnia treatment
  • The American Academy of Sleep Medicine does not specifically recommend mirtazapine in their insomnia guidelines, focusing instead on other agents 1
  • For patients with both depression and insomnia, mirtazapine may be especially beneficial at doses of 15-30 mg 1

Drug Interactions

  • Avoid concurrent use with MAOIs (allow 14 days between stopping one and starting the other) 2
  • Dose adjustments may be needed with:
    • Strong CYP3A inducers (may need to increase mirtazapine dose)
    • Strong CYP3A inhibitors (may need to decrease mirtazapine dose)
    • Cimetidine (may need to decrease mirtazapine dose) 2

By following this dosing approach, mirtazapine can be an effective option for treating insomnia, particularly in patients who may also have depressive symptoms or who have not responded to first-line insomnia treatments.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.